Whey proteins and peptides: Beneficial effects on immune health

Therapy

Volumn 3, Issue 1, 2006, Pages 69-78

  Beaulieu, Josée ^a   Dupont, Claude ^a   Lemieux, Pierre ^b  

^a INRS INSTITUT ARMAND FRAPPIER   (Canada)

^b Technologie Biolactis   (Canada)

Author keywords

Immune; Inflammation; Peptide; Protein; Whey

Indexed keywords

ALPHA LACTALBUMIN; BETA LACTOGLOBULIN; BOVINE SERUM ALBUMIN; CYSTEINE; ESSENTIAL AMINO ACID; GLUTAMINE; GLYCOPROTEIN; IMMUNOGLOBULIN; LACTOFERRICIN; LACTOFERRIN; LIPID; OXAZOLONE; PEPTIDE; PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; WHEY PEPTIDE; WHEY PROTEIN;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CANCER PREVENTION; DRUG ACTIVITY; ENERGY; HUMAN; IMMUNE STATUS; IMMUNOSTIMULATION; INNATE IMMUNITY; INTESTINE LYMPHATIC TISSUE; LIPID BLOOD LEVEL; NONHUMAN; PHYSICAL STRESS;

EID: 33646174838     PISSN: 14750708     EISSN: 1744831X     Source Type: Journal    
DOI: 10.1586/14750708.3.1.69     Document Type: Article

References (92)

1. Tipton KD, Elliott TA, Cree MG, Wolf SE, Sanford AP, Wolfe RR. Ingestion of casein and whey proteins results in muscle anabolism after resistance exercise. Med. Sci Sports Exerc. 36(12), 2073-2081 (2004).
2. Kawase M, Hashimoto H, Hosoda M, Morita H, Hosono A. Effect of administration of fermented milk containing whey protein concentrate to rats and healthy men on serum lipids and blood pressure. J. Dairy Sci. 83(2), 255-263 (2000).
3. Bounous G, Gold P. The biological activity of undenatured dietary whey proteins: role of glutathione. Clin. Invest. Med. 14(4). 296-309 (1991).
4. Bounous G, Molson JH. The antioxidant system. AntiCancer Res. 23(2B), 1411-1415 (2003).
5. Bounous G, Kongshavn PA. Differential effect of dietary protein type on the B-cell and T-cell immune responses in mice. J. Nutr. 115(11), 1403-1408 (1985).
6. Wong KF, Middleton N, Montgomery M, Dey M, Carr RI. Immunostimulation of murine spleen cells by materials associated with bovine milk protein fractions. J. Dairy Sci. 81(7), 1825-1832 (1998).
7. Brix S, Bovetto L, Fritsche R, Barkholt V, Frokiaer H. Immunostimulatory potential of β-lactoglobulin preparations: effects caused by endotoxin contamination. J. Aller. Clin. Imm. 112(6), 1216-1222 (2003).
8. Pellegrini A, Dettling C, Thomas U, Hunziker P. Isolation and characterization of four bactericidal domains in the bovine β-lactoglobulin. Biochim. Biophys. Acta. 1526(2), 131-140 (2001).
9. Guimont C, Marchall E, Girardet JM, Linden G. Biologically active factors in bovine milk and dairy by-products: influence on cell culture. Crit. Rev. Food Sci. Nutr. 37(4), 393-410 (1997).
10. Yamauchi K. Biologically functional proteins of milk and peptides derived from milk proteins. International Dairy Federation Bulletin 272, 51-58 (1992).
11. Pihlanto-Leppala A, Paakkari I, Rinta-Koski M, Antila P. Bioactive peptide derived from in vitro proteolysis of bovine β-lactoglobulin and its effect on smooth muscle. J. Dairy Res. 64(1), 149-155 (1997).
12. Yoshida T, Owens GK. Molecular determinants of vascular smooth muscle cell diversity. Circ. Res. 96(3), 280-291 (2005).
13. Host A. Frequency of cow's milk allergy in childhood. Ann. Allergy Asthma Immunol. 89(6 Suppl. 1), 33-37 (2002).
14. Pecquet S, Bovetto L, Maynard F, Fritsche R. Peptides obtained by tryptic hydrolysis of bovine β-lactoglobulin induce specific oral tolerance in mice. J. Allergy Clin. Immunol. 105(3), 514-521 (2000).
15. Matsumoto H, Shimokawa Y, Ushida Y, Toida T, Hayasawa H. New biological function of bovine α-lactalbumin: protective effect against ethanol- and stress-induced gastric mucosal injury in rats. Biosci. Biotechnol. Biochem. 65(5), 1104-1111 (2001).
16. Bruck WM, Kelleher SL, Gibson GR, Nielsen KE, Chatterton DEW, Lonnerdal B. rRNA probes used to quantify the effects of glycomacropeptide and α-lactalbumin supplementation on the predominant groups of intestinal bacteria of infant rhesus monkeys challenged with enteropathogenic Escherichia coli. J. Ped. Gastr. Nut. 37(3), 273-280 (2003).
17. Bounous G, Stevenson MM, Kongshavn PA. Influence of dietary lactalbumin hydrolysate on the immune system of mice and resistance to salmonellosis. J. Infect. Dis. 144(3), 281 (1981).
18. Bounous G, Letourneau L, Kongshavn PA. Influence of dietary protein type on the immune system of mice. J. Nutr. 113 (7), 1415-1421 (1983).
19. Wong CW, Seow HF, Husband AJ, Regester GO, Watson DL. Effects of purified bovine whey factors on cellular immune functions in ruminants. Vet. Immunol. Immunopathol. 56(1-2), 85-96 (1997).
20. Hakansson A, Andreasson J, Zhivotovsky B, Karpman D, Orrenius S, Svanborg C. Multimeric α-lactalbumin from human milk induces apoptosis through a direct effect on cell nuclei. Exp. Cell Res. 246(2), 451-60 (1999).
21. Svensson M, Hakansson A, Mossberg AK, Linse S, Svanborg C. Conversion of α-lactalbumin to a protein inducing apoptosis. Proc. Natl. Acad. Sci. USA. 97(8), 4221-6 (2000).
22. Gattegno L, Migliore-Samour D, Saffar L, Jolles P. Enhancement of phagocytic activity of human monocytic macrophagic cells by immunostimulating peptides from human casein. Immunol. Lett. 18(1), 27-31 (1988).
23. Jaziri M, Migliore-Samour D, Casabianca-Pignede MR, Keddad K, Morgat JL, Jolles P. Specific binding sites on human phagocytic blood cells for Gly-Leu-Phe and Val-Glu-Pro-Ile-Pro-Tyr, immunostimulating peptides from human milk proteins. Biochim. Biophys. Acta. 1160(3), 251-261 (1992).
24. Migliore-Samour D, Roch-Arveiller M, Tissot M et al. Effects of tripeptides derived from milk proteins on polymorphonuclear oxidative and phosphoinositide metabolisms. Biochem. Pharmacol. 44(4), 673-680 (1992).
25. Kayser H, Meisel H. Stimulation of human peripheral blood lymphocytes by bioactive peptides derived from bovine milk proteins. FEBS Lett. 383(1-2), 18-20 (1996).
26. Pellegrini A, Thomas U, Bramaz N, Hunziker P, von Fellenberg R. Isolation and identification of three bactericidal domains in the bovine α-lactalbumin molecule. Biochim. Biophys. Acta. 1426(3), 439-448 (1999).
27. Baldwin DA, Jenny ER, Aisen P. The effect of human serum transferrin and milk lactoferrin on hydroxyl radical formation from superoxide and hydrogen peroxide. J. Biol. Chem. 259(21), 13391-13394 (1984).
28. Bezwoda WR, Mansoor N. Lactoferrin from human breast milk and from neutrophil granulocytes. Comparative studies of isolation, quantitation, characterization and iron binding properties. Biomed. Chromatogr. 3(3), 121-126 (1989).
29. Masson PL, Heremans JF. Lactoferrin in milk from different species. Comp. Biochem. Physiol. B. 39(1), 119-129 (1971).
30. Masson PL, Heremans JF, Ferin J. Presence of an iron-binding protein (lactoferrin) in the genital tract of the human female I. Its immunohistochemical localization in the endometrium. Fertil. Steril. 19(5), 679-689 (1968).
31. Masson PL, Heremans JF, Schonne E. Lactoferrin, an iron-binding protein in neutrophilic leukocytes. J. Exp. Med. 130(3), 643-658 (1969).
32. Machnicki M, Zimecki M, Zagulski T. Lactoferrin regulates the release of tumour necrosis factor-α and interleukin-6 in vivo. Int. J. Exp. Pathol. 74(5), 433-439 (1993).
33. Dial EJ, Romero JJ, Headon DR, Lichtenberger LM. Recombinant human lactoferrin is effective in the treatment of Helicobacter felis-infected mice. J. Pharm. Pharmacol. 52(12), 1541-1546 (2000).
34. Guillen C, McInnes IB, Vaughan D, Speekenbrink AB, Brock JH. The effects of local administration of lactoferrin on inflammation in murine autoimmune and infectious arthritis. Arthritis Rheum. 43(9), 2073-2080 (2000).
35. Hayashida K, Kaneko T, Takeuchi T, Shimizu H, Ando K, Harada E. Oral administration of lactoferrin inhibits inflammation and nociception in rat adjuvant-induced arthritis. J. Vet. Med. Sci. 66(2), 149-154 (2004).
36. Kimber I, Cumberbatch M, Dearman RJ, Headon DR, Bhushan M, Griffiths CE. Lactoferrin: influences on Langerhans cells, epidermal cytokines, and cutaneous inflammation. Biochem. Cell Biol. 80(1), 103-107 (2002).
37. Britigan BE, Lewis TS, Waldschmidt M, McCormick ML, Krieg AM. Lactoferrin binds CpG-containing oligonucleotides and inhibits their immunostimulatory effects on human B-cells. J. Immunol. 167(5), 2921-2928 (2001).
38. Broxmeyer HE, DeSousa M, Smithyman A et al. Specificity and modulation of the action of lactoferrin, a negative feedback regulator of myelopoiesis. Blood 55(2), 324-333 (1980).
39. Bagby GC, Jr., Rigas VD, Bennett RM, Vandenbark AA, Garewal HS. Interaction of lactoferrin, monocytes, and T-lymphocyte subsets in the regulation of steady-state granulopoiesis in vitro. J. Clin. Invest. 68(1), 56-63 (1981).
40. Bagby GC, Jr. Regulation of granulopoiesis: the lactoferrin controversy. Blood Cells 15(2), 386-399 (1989).
41. Crouch SP, Slater KJ, Fletcher J. Regulation of cytokine release from mononuclear cells by the iron-binding protein lactoferrin. Blood 80(1), 235-240 (1992).
42. Zimecki M, Mazurier J, Machnicki M, Wieczorek Z, Montreuil J, Spik G. Immunostimulatory activity of lactotransferrin and maturation of CD4-CD8- murine thymocytes. Immunol. Lett. 30(1), 119-123 (1991).
43. Zimecki M, Mazurier J, Spik G, Kapp JA. Human lactoferrin induces phenotypic and functional changes in murine splenic B-cells. Immunology 86(1), 122-127 (1995).
44. Sekine K, Ushida Y, Kuhara T et al. Inhibition of initiation and early stage development of aberrant crypt foci and enhanced natural killer activity in male rats administered bovine lactoferrin concomitantly with azoxymethane. Cancer Letter 121(2), 211-216 (1997).
45. Iigo M, Kuhara T, Ushida Y, Sekine K, Moore MA, Tsuda H. Inhibitory effects of bovine lactoferrin on colon carcinoma 26 lung metastasis in mice. Clin. Exp. Metastasis 17(1), 35-40 (1999).
46. Debbabi H, Dubarry M, Rautureau M, Tome D. Bovine lactoferrin induces both mucosal and systemic immune response in mice. J. Dairy Res. 65(2), 283-293 (1998).
47. Wang WP, Iigo M, Sato J, Sekine K, Adachi I, Tsuda H. Activation of intestinal mucosal Immunity in tumor-bearing mice by lactoferrin. Jpn. J. Cancer Res. 91(10), 1022-1027 (2000).
48. Griffiths EA, Duffy LC, Schanbacher FL et al. In vivo effects of bifidobacteria and lactoferrin on gut endotoxin concentration and mucosal immunity in balb/c mice. Dig. Dis. Sci. 49(4), 579-589 (2004).
49. Weiner HL. Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol. Today 18(7), 335-343 (1997).
50. Miyauchi H, Hashimoto S, Nakajima M, Shinoda I, Fukuwatari Y, Hayasawa H. Bovine lactoferrin stimulates the phagocytic activity of human neutrophils: identification of its active domain. Cell. Immunol. 187(1), 34-37 (1998).
51. Shinoda I, Takase M, Fukuwatari Y, Shimamura S, Koller M, Konig W. Effects of lactoferrin and lactoferricin on the release of interleukin-8 from human polymorphonuclear leukocytes. Biosci. Biotechnol. Biochem. 60(3), 521-523 (1996).
52. Dawes ME, Lakritz J, Tyler JW et al. Effects of supplemental lactoferrin on serum lactoferrin and IgG concentrations and neutrophil oxidative metabolism in Holstein calves. J. Vet. Int. Med. 18(1), 104-108 (2004).
53. Mattsby-Baltzer I, Roseanu A, Motas C, Elverfors J, Engberg I, Hanson LA. Lactoferrin or a fragment thereof inhibits the endotoxin-induced interleukin-6 response in human monocytic cells. Pediatr. Res. 40(2), 257-262 (1996).
54. Yoo YC, Watanabe R. Koike Y et al. Apoptosis in human leukemic cells induced by lactoferricin, a bovine milk protein-derived peptide: involvement of reactive oxygen species. Biochem. Biophys. Res. Commun. 237(3), 624-628 (1997).
55. Janeway CA, Travers P. Immunobiologie (2nd Edition). De Boeck et Larcier, Paris, France, (1996).
56. Roos N, Mahe S, Benamouzig R, Sick H, Rautureau J, Tome D. 15N-labeled immunoglobulins from bovine colostrum are partially resistant to digestion in human intestine. J. Nutr. 125(5), 1238-1244 (1995).
57. Ng TB, Ye XY. A polymeric immunoglobulin receptor-like milk protein with inhibitory activity on human immunodeficiency virus type 1 reverse transcriptase. Int. J. Bioch. Cell. Biol. 36(11), 2242-2249 (2004).
58. Bounous G, Batist G, Gold P. Immunoenhancing property of dietary whey protein in mice: role of glutathione. Clin. Invest. Med. 12(3), 154-161 (1989).
59. Otani H, Monnai M, Hosono A. Bovine kappa-casein as inhibitor of the proliferation of mouse splenocytes induced by lipopolysaccharide stimulation. Milchwissenschaft 47, 512-515 (1992).
60. Otani H, Hata I. Inhibition of proliferative responses of mouse spleen lymphocytes and rabbit Peyer's patch cells by bovine milk caseins and their digests. J. Dairy Res. 62(2), 339-348 (1995).
61. Otani H, Monnai M, Kawasaki Y, Kawakami H, Tanimoto M. Inhibition of mitogen-induced proliferative responses of lymphocytes by bovine κ-caseinoglycopeptides having different carbohydrate chains. J. Baby Res. 62(2), 349-357 (1995).
62. Li EW, Mine Y. Immunoenhancing effects of bovine glycomacropeptide and its derivatives on the proliferative response and phagocytic activities of human macrophagelike cells, U937. J. Agric. Food. Chem. 52(9), 2704-2708 (2004).
63. Bounous G, Shenouda N, Kongshavn PA, Osmond DG. Mechanism of altered B-cell response induced by changes in dietary protein type in mice. J. Nutr. 115(11), 1409-1417 (1985).
64. Bounous G, Kongshavn PA, Gold P. The immunoenhancing property of dietary whey protein concentrate. Clin. Invest. Med. 11(4), 271-278 (1988).
65. Wong CW, Watson DL. Immunomodulatory effects of dietary whey proteins in mice. J. Dairy Res. 62(2), 359-368 (1995).
66. Low PPL, Rutherfurd KJ, Gill HS, Cross ML. Effect of dietary whey protein concentrate on primary and secondary antibody responses in immunized BALB/c mice. Int. Immunopharmacol. 3(3), 393-401 (2003).
67. Middleton N, Reid JR, Coolbear T, Jelen P. Proliferation and intracellular glutathione in Jurkat T-cells with concentrated whey protein products. Int. Dairy J. 13(7), 565-573 (2003).
68. Mercier A, Gauthier SF, Fliss L. Immunomodulating effects of whey proteins and their enzymatic digests. Int. Dairy J. 14(3), 175-183 (2004).
69. Low PPL, Rutherfurd KJ, Cross ML, Gill HS. Enhancement of mucosal antibody responses by dietary whey protein concentrate. Food Agri. Imm. 13, 255-264 (2001).
70. Roth JA, Frank DE, Weighner P, Weighner M. Enhancement of neutrophil function by ultrafiltered bovine whey. J. Dairy Sci. 84(4), 824-829 (2001).
71. Otani H, Odashima M. Inhibition of proliferative responses of mouse spleen lymphocytes by lacto- and ovotransferrins. Food Agri. Imm. 9, 193-201 (1997).
72. Cross ML, Gill HS. Modulation of immune function by a modified bovine whey protein concentrate. Immunol. Cell. Biol. 77(4), 345-350 (1999).
73. Penttila IA, Zhang MF, Bates E, Regester G, Read LC, Zola H. Immune modulation in suckling rat pups by a growth factor extract derived from milk whey. J. Dairy Res. 68(4), 587-599 (2001).
74. Yun SS, Sugita-Konishi Y, Kumagai S, Yamauchi K. Isolation of mitogenic glycophosphopeptides from cheese whey protein concentrate. Biosci. Biotechnol. Biochem. 60(3), 429-433 (1996).
75. Amiot J, Germain L, Turgeon S, Lemay M, OrySalam C, Auger FA. Peptides from milk protein hydrolysates to improve the growth of human keratinocytes in culture. Int. Dairy J. 14(7), 619-626 (2004).
76. Murakami M, Tonouchi H, Takahashi R et at. Structural analysis of a new antihypertensive peptide (β-lactosin B) isolated from a commercial whey product. J. Dairy Sci. 87(7), 1967-1974 (2004).
77. Han YS, Park HY, Ahn KM, Lee JS, Choi HM, Lee SI. Short-term effect of partially hydrolyzed formula on the prevention of development of atopic dermatitis in infants at high risk. J. Korean Med. Sci. 18(4), 547-551 (2003).
78. Tanabe S, Tesaki S, Watanabe J, Fukushi E, Sonoyama K, Kawabata J. Isolation and structural elucidation of a peptide derived from Edam cheese that inhibits β-lactoglobulin transport. J. Dairy Sci. 86(2), 464-468 (2003).
79. Peng HJ, Su SN, Tsai JJ, Tsai LC, Kuo HL, Kuo SW. Effect of ingestion of cow's milk hydrolysed formulae on whey protein-specific Th2 immune responses in naive and sensitized mice. Clin. Exp. Allergy 34(4), 663-670 (2004).
80. Grosvenor CE, Picciano MF, Baumrucker CR. Hormones and growth factors in milk. Endocr. Rev. 14(6), 710-728 (1993).
81. Garofalo RP, Goldman AS. Cytokines, chemokines, and colony-stimulating factors in human milk: the 1997 update. Biol. Neonate 74(2), 134-142 (1998).
82. Rowlands JC, He L, Hakkak R, Ronis MJ, Badger TM. Soy and whey proteins downregulate DMBA-induced liver and mammary gland CYP1 expression in female rats. J. Nutr. 131(12), 3281-3287 (2001).
83. Procaccino F, Reinshagen M, Hoffmann P et al. Protective effect of epidermal growth factor in an experimental model of colitis in rats. Gastroenterology 107(1), 12-17 (1994).
84. Porter SN, Howarth GS, Butler RN. An orally administered growth factor extract derived from bovine whey suppresses breath ethane in colitic rats. Scand. J. Gastroenterol. 33(9), 967-974 (1998).
85. Francis GL, Regester GO, Webb HA, Ballard FJ. Extraction from cheese whey by cation-exchange chromatography of factors that stimulate the growth of mammalian cells. J. Dairy Sci. 78(6), 1209-1218 (1995).
86. Rogers ML, Belford DA, Francis GL, Ballard FJ. Identification of fibroblast growth factors in bovine cheese whey. J. Dairy Res. 62(3), 501-507 (1995).
87. Hilliam M. The market for functional foods. Int. Dairy J. 8, 349-353 (1998).
88. Milner JA. Functional foods: the US perspective. Am. J. Clin. Nutr 71(6 Suppl), 1654S-1659S (2000).
89. Meydani SN, Ha WK. Immunologic effects of yogurt. Am. J. Clin. Nutr. 71(4), 861-872 (2000).
90. de Wit JN. Marschall Rhone-Poulenc Award Lecture. Nutritional and functional characteristics of whey proteins in food products. J. Dairy Sci. 81(3), 597-608 (1998).
91. Marshall KR, Harper WJ. Trends in utilization of whey and whey derivatives. Bulletin of the International Dairy Federation 233, 21-32 (1988).
92. Cayot P, Lorient D. Structures et technofonctions des protéines du lait. Arilait Recherches, Paris, France, 37-182 (1998).